These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 6147547)
61. Intrathecal synthesis of antibodies to HTLV-III in patients without AIDS or AIDS related complex. Goudsmit J; Wolters EC; Bakker M; Smit L; Van der Noordaa J; Hische EA; Tutuarima JA; Van der Helm HJ Br Med J (Clin Res Ed); 1986 May; 292(6530):1231-4. PubMed ID: 3011184 [TBL] [Abstract][Full Text] [Related]
62. Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Goedert JJ; Biggar RJ; Weiss SH; Eyster ME; Melbye M; Wilson S; Ginzburg HM; Grossman RJ; DiGioia RA; Sanchez WC Science; 1986 Feb; 231(4741):992-5. PubMed ID: 3003917 [TBL] [Abstract][Full Text] [Related]
63. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings. Essex M; McLane MF; Kanki P; Allan J; Kitchen L; Lee TH Cancer Res; 1985 Sep; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682 [TBL] [Abstract][Full Text] [Related]
64. Contact tracing in the acquired immune deficiency syndrome (AIDS). Evidence for transmission of virus and disease by an asymptomatic carrier. Cooper DA; Gold J; May W; Kaminsky LS; Penny R; Levy JA Med J Aust; 1984 Oct; 141(9):579-82. PubMed ID: 6092883 [TBL] [Abstract][Full Text] [Related]
65. Immunological alterations in anti-HTLV-III negative haemophiliacs and homosexual men in Hungary. Hollán SR; Füst G; Nagy K; Horváth A; Králl G; Verebélyi K; Ujhelyi E; Varga L; Mayer V Immunol Lett; 1985; 11(5-6):305-10. PubMed ID: 3005163 [TBL] [Abstract][Full Text] [Related]
66. Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome. Brun-Vezinet F; Rouzioux C; Barre-Sinoussi F; Klatzmann D; Saimot AG; Rozenbaum W; Christol D; Gluckmann JC; Montagnier L; Chermann JC Lancet; 1984 Jun; 1(8389):1253-6. PubMed ID: 6144973 [TBL] [Abstract][Full Text] [Related]
67. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic. Evatt BL; Gomperts ED; McDougal JS; Ramsey RB N Engl J Med; 1985 Feb; 312(8):483-6. PubMed ID: 2982095 [TBL] [Abstract][Full Text] [Related]
68. Serological characterization of HTLV-III infection in AIDS and related disorders. Groopman JE; Chen FW; Hope JA; Andrews JM; Swift RL; Benton CV; Sullivan JL; Volberding PA; Sites DP; Landesman S J Infect Dis; 1986 Apr; 153(4):736-42. PubMed ID: 3005434 [TBL] [Abstract][Full Text] [Related]
69. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822 [TBL] [Abstract][Full Text] [Related]
71. Variation in human T lymphotropic virus III (HTLV-III) antibodies in homosexual men: decline before onset of illness related to acquired immune deficiency syndrome (AIDS). Biggar RJ; Melbye M; Ebbesen P; Alexander S; Nielsen JO; Sarin P; Faber V Br Med J (Clin Res Ed); 1985 Oct; 291(6501):997-8. PubMed ID: 2996691 [TBL] [Abstract][Full Text] [Related]
72. Antibodies to HTLV-III in patients with acquired immunodeficiency or lymphadenopathy syndrome in West Germany. Hehlmann R; Kreeb G; Erfle V; Piechowiak H; Krüger G; Goebel FD Lancet; 1984 Nov; 2(8411):1094. PubMed ID: 6150160 [No Abstract] [Full Text] [Related]
74. HTLV-III antibody in Sydney homosexual men. Robertson PW; Young PS Med J Aust; 1985 Sep; 143(6):261. PubMed ID: 2993831 [No Abstract] [Full Text] [Related]
75. Virologic studies in a case of transfusion-associated AIDS. Groopman JE; Salahuddin SZ; Sarngadharan MG; Mullins JI; Sullivan JL; Mulder C; O'Hara CJ; Cheeseman SH; Haverkos H; Forgacs P N Engl J Med; 1984 Nov; 311(22):1419-22. PubMed ID: 6092957 [TBL] [Abstract][Full Text] [Related]
76. Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS. Kalyanaraman VS; Cabradilla CD; Getchell JP; Narayanan R; Braff EH; Chermann JC; Barré-Sinoussi F; Montagnier L; Spira TJ; Kaplan J Science; 1984 Jul; 225(4659):321-3. PubMed ID: 6330889 [TBL] [Abstract][Full Text] [Related]
77. The value of haematological screening for AIDS in an at risk population. Weber JN; Walker D; Engelkins H; Bain B; Harris JR Genitourin Med; 1985 Oct; 61(5):325-9. PubMed ID: 2995238 [TBL] [Abstract][Full Text] [Related]
78. The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells. Schechter MT; Boyko WJ; Jeffries E; Willoughby B; Nitz R; Constance P; Weaver M; Wiggs B; O'Shaughnessy M Can Med Assoc J; 1985 Aug; 133(4):286-92. PubMed ID: 2990652 [TBL] [Abstract][Full Text] [Related]
79. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia. Jason JM; McDougal JS; Dixon G; Lawrence DN; Kennedy MS; Hilgartner M; Aledort L; Evatt BL JAMA; 1986 Jan; 255(2):212-5. PubMed ID: 3001375 [TBL] [Abstract][Full Text] [Related]
80. A report of three cases of AIDS in Thailand. Phanuphak P; Locharernkul C; Panmuong W; Wilde H Asian Pac J Allergy Immunol; 1985 Dec; 3(2):195-9. PubMed ID: 2866780 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]